Parenteral versus oral iron therapy for adults and children with chronic kidney disease

Jumana Albaramki; Elisabeth M. Hodson; Jonathan C. Craig

doi:10.1002/14651858.CD007857

Parenteral versus oral iron therapy for adults and children with chronic kidney disease

Jumana Albaramki, Elisabeth M. Hodson, Jonathan C. Craig

Flinders University

Research output: Contribution to journal › Review article › peer-review

17 Citations (Scopus)

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

The objective of this systematic review is to determine the benefits and harms of IV iron supplementation compared with oral iron in patients with CKD, treated with haemodialysis, peritoneal dialysis or are not receiving dialysis. The review will examine the effects of these interventions on achieving target levels of Hb and iron parameters, in reduced doses of ESA required and on mortality, hospitalisation, cardiac function, quality of life as well as determining adverse effects of the therapies.

Original language	English
Article number	CD007857
Journal	Cochrane Database of Systematic Reviews
Issue number	3
DOIs	https://doi.org/10.1002/14651858.CD007857
Publication status	Published - 8 Jul 2009

Keywords

iron supplementation
kidney disease
interventions

Access to Document

10.1002/14651858.CD007857

Fingerprint Dive into the research topics of 'Parenteral versus oral iron therapy for adults and children with chronic kidney disease'. Together they form a unique fingerprint.

Cite this

@article{a14016c1196642a6b0e3fc6670543f58,

title = "Parenteral versus oral iron therapy for adults and children with chronic kidney disease",

abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:The objective of this systematic review is to determine the benefits and harms of IV iron supplementation compared with oral iron in patients with CKD, treated with haemodialysis, peritoneal dialysis or are not receiving dialysis. The review will examine the effects of these interventions on achieving target levels of Hb and iron parameters, in reduced doses of ESA required and on mortality, hospitalisation, cardiac function, quality of life as well as determining adverse effects of the therapies.",

keywords = "iron supplementation, kidney disease, interventions",

author = "Jumana Albaramki and Hodson, {Elisabeth M.} and Craig, {Jonathan C.}",

year = "2009",

month = jul,

day = "8",

doi = "10.1002/14651858.CD007857",

language = "English",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "UPDATE SOFTWARE LTD",

number = "3",

}

TY - JOUR

T1 - Parenteral versus oral iron therapy for adults and children with chronic kidney disease

AU - Albaramki, Jumana

AU - Hodson, Elisabeth M.

AU - Craig, Jonathan C.

PY - 2009/7/8

Y1 - 2009/7/8

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:The objective of this systematic review is to determine the benefits and harms of IV iron supplementation compared with oral iron in patients with CKD, treated with haemodialysis, peritoneal dialysis or are not receiving dialysis. The review will examine the effects of these interventions on achieving target levels of Hb and iron parameters, in reduced doses of ESA required and on mortality, hospitalisation, cardiac function, quality of life as well as determining adverse effects of the therapies.

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:The objective of this systematic review is to determine the benefits and harms of IV iron supplementation compared with oral iron in patients with CKD, treated with haemodialysis, peritoneal dialysis or are not receiving dialysis. The review will examine the effects of these interventions on achieving target levels of Hb and iron parameters, in reduced doses of ESA required and on mortality, hospitalisation, cardiac function, quality of life as well as determining adverse effects of the therapies.

KW - iron supplementation

KW - kidney disease

KW - interventions

U2 - 10.1002/14651858.CD007857

DO - 10.1002/14651858.CD007857

M3 - Review article

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1469-493X

IS - 3

M1 - CD007857

ER -